Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Agios Soars on Plan to Sell Cancer Drugs, Return $1.2B to Holders
By Vidhi Choudhary
Dec 21, 2020 9:30 AM EST
PRESS RELEASES
Agios Announces Phase 3 ACTIVATE-T Trial Of Mitapivat Achieved Primary Endpoint In Adults With Pyruvate Kinase Deficiency Who Are Regularly Transfused
By GlobeNewswire
Jan 26, 2021 4:01 PM EST
PRESS RELEASES
Agios Presents Final Data From Phase 3 ClarIDHy Study Of TIBSOVO® (ivosidenib Tablets) In Patients With Previously Treated IDH1-Mutant Cholangiocarcinoma
By GlobeNewswire
Jan 17, 2021 10:00 AM EST
PRESS RELEASES
Agios To Present At The 39th Annual J.P. Morgan Healthcare Conference On Monday, January 11, 2021
By GlobeNewswire
Jan 5, 2021 7:00 AM EST
INVESTING
Agios Soars on Plan to Sell Cancer Drugs, Return $1.2B to Holders
By Vidhi Choudhary
Dec 21, 2020 9:30 AM EST
PRESS RELEASES
Agios Announces Updated Data From Phase 1 Study Of Mitapivat, First-in-Class PKR Activator, In Sickle Cell Disease
By GlobeNewswire
Dec 7, 2020 4:30 PM EST
PRESS RELEASES
Agios Launches Anemia ID, A No-Cost Genetic Testing Program For Hereditary Anemias
By GlobeNewswire
Nov 30, 2020 7:00 AM EST
PRESS RELEASES
Agios To Present At The Piper Sandler 32nd Annual Virtual Healthcare Conference On Wednesday, December 2, 2020
By GlobeNewswire
Nov 25, 2020 7:00 AM EST
PRESS RELEASES
Agios Announces FDA Orphan Drug Designation Granted To Mitapivat For Treatment Of Sickle Cell Disease
By GlobeNewswire
Nov 12, 2020 4:30 PM EST
PRESS RELEASES
Agios To Present Broad Set Of Clinical And Translational Data For Oncology And Rare Genetic Disease Programs At The Virtual 2020 ASH Annual Meeting
By GlobeNewswire
Nov 4, 2020 11:45 AM EST
PRESS RELEASES
Agios To Host A Webinar On Its Pyruvate Kinase-R (PKR) Activation Clinical Programs And Commercial Outlook On Thursday, November 19, 2020
By GlobeNewswire
Oct 29, 2020 4:01 PM EDT
PRESS RELEASES
Agios To Webcast Conference Call Of Third Quarter 2020 Financial Results On November 5, 2020
By GlobeNewswire
Oct 22, 2020 7:00 AM EDT
PRESS RELEASES
Agios Announces Withdrawal Of European Marketing Authorization Application For TIBSOVO® As A Treatment For Relapsed Or Refractory IDH1-mutant Acute Myeloid Leukemia
By GlobeNewswire
Oct 16, 2020 4:01 PM EDT
PRESS RELEASES
Agios Appoints Jonathan Biller As Chief Financial Officer, Head Of Legal And Corporate Affairs
By GlobeNewswire
Sep 8, 2020 4:01 PM EDT
PRESS RELEASES
Agios To Present At The Citi 15th Annual BioPharma Virtual Conference On Wednesday, September 9, 2020
By GlobeNewswire
Aug 27, 2020 7:00 AM EDT
PRESS RELEASES
Agios To Present At The Virtual Canaccord 40th Annual Growth Conference On Thursday, August 13, 2020
By GlobeNewswire
Aug 6, 2020 7:00 AM EDT
PRESS RELEASES
Agios To Webcast Conference Call Of Second Quarter 2020 Financial Results On July 30, 2020
By GlobeNewswire
Jul 16, 2020 7:01 AM EDT
PRESS RELEASES
Agios To Present At The BMO 2020 Prescriptions For Success Healthcare Virtual Conference On Tuesday, June 23, 2020
By GlobeNewswire
Jun 17, 2020 4:01 PM EDT
PRESS RELEASES
Agios And Royalty Pharma Announce $255 Million Purchase Agreement For IDHIFA® Royalty
By GlobeNewswire
Jun 12, 2020 6:30 AM EDT
PRESS RELEASES
Agios Announces FDA Orphan Drug Designation Granted To Mitapivat For Treatment Of Thalassemia
By GlobeNewswire
Jun 8, 2020 4:01 PM EDT
PRESS RELEASES
Agios To Present Updated Clinical Proof-of-Concept Data From The Phase 2 Study Of Mitapivat In Thalassemia In Oral Presentation At The European Hematology Association Annual Congress
By GlobeNewswire
May 14, 2020 9:41 AM EDT
PRESS RELEASES
Agios To Present Updated Data From The Phase 1 Study Of Vorasidenib In Non-enhancing Glioma In Oral Presentation At The American Society Of Clinical Oncology Annual Meeting
By GlobeNewswire
May 13, 2020 5:01 PM EDT
PRESS RELEASES
Agios To Present At The RBC Capital Markets Global Healthcare Virtual Conference On Tuesday, May 19, 2020
By GlobeNewswire
May 12, 2020 7:00 AM EDT
PRESS RELEASES
Agios To Webcast Conference Call Of First Quarter 2020 Financial Results On April 30, 2020
By GlobeNewswire
Apr 16, 2020 7:00 AM EDT
PRESS RELEASES
Agios Receives Positive Opinion On Orphan Drug Designation From The European Medicines Agency For Mitapivat In Pyruvate Kinase Deficiency
By GlobeNewswire
Mar 30, 2020 4:01 PM EDT
